Taken together, these results indicated that DUSP13 as a downstream target of the PVT1/DUSP13 axis was involved in the modulation of lipid metabolism that might be a potential mechanism facilitating the MVI process in patients with HCC. This evidence concerns the gene DUSP13B and hepatocellular carcinoma.